Derakhshan Behrad

CIK 00018531091 companyBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001853109

Recent Transactions

46 trades

Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-08-12+5,781→ 29,426 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2026-08-12+100,000→ 100,000 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2026-08-12+100,000→ 100,000 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2026-08-12+50,000→ 50,000 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2026-08-12−7,500→ 22,500 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2026-08-12−5,781→ 11,563 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-08-12$43.70/sh−2,475→ 31,826 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-08-12$44.44/sh−150→ 34,301 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-08-12$44.50/sh−304→ 34,451 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-08-12$43.79/sh−2,171→ 34,755 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-08-12+7,500→ 36,926 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-08-12+180,000→ 180,000 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-08-12+5,781→ 26,136 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-08-12$13.39/sh−2,491→ 23,645 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2025-08-12−5,781→ 17,344 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2025-08-12+30,000→ 30,000 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-05-02$16.45/sh−1,691→ 20,355 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-05-01+5,209→ 22,046 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2025-05-01−5,209→ 0 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-02-05$1.93/sh+10,000→ 26,837 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-02-05$30.03/sh−10,000→ 16,837 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-02-05−10,000→ 92,929 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-09-20−42,068→ 102,949 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-09-20$1.93/sh+42,068→ 57,189 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-09-20$29.03/sh−42,068→ 15,121 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-08-12+138,750→ 138,750 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2024-08-12+23,125→ 23,125 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-05-02$18.91/sh−1,718→ 13,422 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2024-05-01−5,208→ 5,209 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-05-01+5,208→ 15,140 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-02-09$20.04/sh−4,800→ 7,020 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-02-09$1.93/sh+4,800→ 11,820 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-02-09−4,800→ 145,017 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-02-08−4,600→ 149,817 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-02-08$1.93/sh+4,600→ 11,620 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-02-08$20.01/sh−4,600→ 7,020 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-02-07−600→ 154,417 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-02-07$20.00/sh−600→ 7,020 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-02-07$1.93/sh+600→ 7,620 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2023-08-17+220,000→ 220,000 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2023-05-02$8.90/sh−1,747→ 7,020 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2023-05-01−5,208→ 10,417 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2023-05-01+5,208→ 8,767 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2022-08-08+200,000→ 200,000 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2022-05-01+15,625→ 15,625 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2021-08-17+140,000→ 140,000 total

Companies

Edgewise Therapeutics, Inc.
Chief Business Officer
$EWTX

Recent Filings

Address

C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET

BOULDER, CO, 80301

View on SEC.gov